Immunological reclassification of 22 children with a former diagnosis of non-T, non-B ALL.

HL-A antigens and diabetes mellitus. Lancet (1974) 4.42

HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens (1974) 4.41

HLA and disease 1982--a survey. Immunol Rev (1983) 3.87

Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

HL-A and disease associations--a survey. Transplant Rev (1975) 2.87

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85

Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83

Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet (1997) 2.70

Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41

Reverse branch migration of Holliday junctions by RecG protein: a new mechanism for resolution of intermediates in recombination and DNA repair. Cell (1993) 2.31

Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet (1995) 2.31

A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31

Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24

Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11

HL-A antigens and multiple sclerosis. Lancet (1972) 2.09

Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment. Pediatr Hematol Oncol (1992) 1.99

HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature (1983) 1.99

MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97

Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92

Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89

Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87

[Diagnosis and treatment in general practice. 6. Attitudes of general practitioners--a study in Copenhagen County]. Ugeskr Laeger (1989) 1.84

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS (1997) 1.83

Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83

HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (1981) 1.78

Genetics of HLA disease association. Annu Rev Genet (1981) 1.74

Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature (1977) 1.69

Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63

Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62

Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57

Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol (1998) 1.57

Vitamin K regimens and incidence of childhood cancer in Denmark. BMJ (1994) 1.55

Incidence of childhood cancer in Denmark 1943-1984. Int J Epidemiol (1989) 1.54

Intramedullary pressure and bone marrow fat extravasation in reamed and unreamed femoral nailing. J Orthop Res (1999) 1.53

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) Acta Paediatr (1998) 1.53

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia (2007) 1.52

CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50

Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet (1994) 1.50

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med (2000) 1.49

Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol (1998) 1.47

Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47

Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer (2000) 1.46

The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ (1993) 1.44

HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43

Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol (1988) 1.40

Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40

Four pairs of siblings with acute leukemia during 1966-1985 in the Nordic countries: indication of an elevated familial risk? Pediatr Hematol Oncol (1990) 1.39

[Transplantation. Blood, bone marrow and solid organs]. Ugeskr Laeger (2000) 1.39

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38

The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum (2000) 1.37

Quantitation of gastrointestinal protein loss by means of FE59-labeled iron dextran. Gastroenterology (1968) 1.37

Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37

HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36

Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet (1992) 1.35

HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J Immunol (1989) 1.35

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol (1998) 1.33

Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32

Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA system. Am J Hum Genet (1983) 1.25

Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J (Clin Res Ed) (1987) 1.22

Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A (1999) 1.22

Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21

Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Cancer (1984) 1.21

Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 1.20

HLA and disease. Transplant Proc (1977) 1.19

HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies. Br J Dermatol (1974) 1.18

Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Leukemia (2005) 1.18

Direct spectrometric determination of the concentration of bilirubins in serum. Scand J Clin Lab Invest (1974) 1.17

A linkage study of hereditary ataxias and related disorders. Evidence of heterogeneity of dominant cerebellar ataxia. Hum Genet (1980) 1.14

Letter: HL-A and idiopathic Addison's disease. Lancet (1974) 1.14

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14

A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol (1990) 1.14

Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol (1994) 1.14

The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenetics (1990) 1.13

An HLA map of Europe. Hum Hered (1978) 1.13

Acute respiratory tract infections in children. A three-year follow-up from birth. Acta Paediatr Scand (1990) 1.13

HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens (1973) 1.11

The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11

Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab (1999) 1.10

MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet (1998) 1.10

The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis. Genet Epidemiol (1985) 1.08

Letter: Lack of antigen response to myxoviruses in multiple sclerosis. Lancet (1973) 1.08

HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08